{"id":3002,"date":"2024-03-10T13:16:50","date_gmt":"2024-03-10T10:16:50","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=3002"},"modified":"2024-03-10T13:16:51","modified_gmt":"2024-03-10T10:16:51","slug":"turk-kardiyoloji-dernegi-kadin-kalbini-anlatti","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=3002","title":{"rendered":"T\u00fcrk Kardiyoloji Derne\u011fi \u2018Kad\u0131n Kalbi\u2019ni Anlatt\u0131"},"content":{"rendered":"\n<p><em><strong>T\u00fcrkiye&#8217;nin iyile\u015ftiren g\u00fcc\u00fc Abdi \u0130brahim\u2019in ko\u015fulsuz deste\u011fi ile T\u00fcrk Kardiyoloji Derne\u011fi taraf\u0131ndan d\u00fczenlenen \u2018Kad\u0131n Kalbi\u2019 isimli webinarda, kad\u0131nlarda kalp-damar sa\u011fl\u0131\u011f\u0131 hakk\u0131nda bilgi ve veriler payla\u015f\u0131ld\u0131. TKD Y\u00f6netim Kurulu \u00dcyesi, TKD Kad\u0131n ve Kalp Sa\u011fl\u0131\u011f\u0131 Proje Grubu Koordinat\u00f6r\u00fc Do\u00e7. Dr. Fahriye Vatansever A\u011fca ve&nbsp;TKD Kad\u0131n ve Kalp Sa\u011fl\u0131\u011f\u0131 Proje Grubu Ba\u015fkan\u0131 Prof. Dr. \u015eule Karakelleo\u011flu,&nbsp;kalp hastal\u0131klar\u0131n\u0131n kad\u0131nlarda \u00e7ok daha seyrek g\u00f6r\u00fcld\u00fc\u011f\u00fc y\u00f6n\u00fcndeki yanl\u0131\u015f inan\u0131\u015fa dikkat \u00e7ekmek ve toplumda fark\u0131ndal\u0131k yaratmak i\u00e7in webinar\u0131 \u00f6zellikle 8 Mart D\u00fcnya Kad\u0131nlar G\u00fcn\u00fc\u2019nde d\u00fczenlediklerini ifade etti.&nbsp;<\/strong><\/em><\/p>\n\n\n\n<p>T\u00dcRK Kardiyoloji Derne\u011fi (TKD), 8 Mart Kad\u0131nlar G\u00fcn\u00fc\u2019ne \u00f6zel olarak d\u00fczenledi\u011fi webinar\u2019da, kad\u0131nlarda kalp sa\u011fl\u0131\u011f\u0131 konusunda \u00f6nemli bilgiler verdi. Abdi \u0130brahim\u2019in ko\u015fulsuz deste\u011fiyle ve TKD \u00fcyelerinin yan\u0131 s\u0131ra halka a\u00e7\u0131k d\u00fczenlenen \u201cKad\u0131n Kalbi\u201d isimli webinarda, kalp-damar hastal\u0131klar\u0131n\u0131n toplumda en s\u0131k \u00f6l\u00fcm nedeni oldu\u011funa i\u015faret edildi ve TKD\u2019nin \u00e7al\u0131\u015fmalar\u0131 hakk\u0131nda bilgi verildi.&nbsp;<\/p>\n\n\n\n<p><strong>Prof Dr. \u015eule Karakelleo\u011flu<\/strong>&nbsp;ve <strong>Prof. Dr. Saide Aytekin<\/strong> moderat\u00f6rl\u00fc\u011f\u00fcnde; <strong>Do\u00e7. Dr. Fahriye Vatansever A\u011fca, Prof. Dr. \u0130rem Din\u00e7er, Prof. Dr. \u00d6zlem Y\u0131ld\u0131r\u0131mt\u00fcrk<\/strong> ve <strong>Prof. Dr. Gamze Babur G\u00fcler\u2019in<\/strong> konu\u015fmac\u0131 olarak kat\u0131ld\u0131\u011f\u0131 webinarda, kad\u0131nlarda kalp sa\u011fl\u0131\u011f\u0131 konusunda fark\u0131ndal\u0131k yaratmak amac\u0131yla, \u201ck\u0131rm\u0131z\u0131 alarm\u201d\u0131 \u00e7a\u011fr\u0131\u015ft\u0131rmas\u0131 a\u00e7\u0131s\u0131ndan \u2018k\u0131rm\u0131z\u0131 renk konsepti\u2019 uyguland\u0131.&nbsp;<\/p>\n\n\n\n<p><strong>Her 3 kad\u0131ndan birinin \u00f6l\u00fcm nedeni kalp hastal\u0131klar\u0131<\/strong><\/p>\n\n\n\n<p>Genel kan\u0131n\u0131n aksine kalp-damar hastal\u0131klar\u0131n\u0131n kad\u0131nlar ve erkeklerde \u00e7ok yak\u0131n oranlarda g\u00f6r\u00fclmesi ve her 3 kad\u0131ndan birinin \u00f6l\u00fcm\u00fcne yol a\u00e7mas\u0131 nedeniyle, 8 Mart D\u00fcnya Kad\u0131nlar G\u00fcn\u00fc\u2019nde d\u00fczenlenen webinarda, koroner kalp hastal\u0131klar\u0131n\u0131n kad\u0131nlardaki seyri, tan\u0131 y\u00f6ntemleri ve tan\u0131s\u0131ndaki g\u00fc\u00e7l\u00fckler, kad\u0131nlarda kalp yetmezli\u011fi nedenleri, gebelikte kalp hastal\u0131klar\u0131n\u0131n tan\u0131 ve tedavisi gibi son derece \u00f6nemli konu ba\u015fl\u0131klar\u0131 ele al\u0131nd\u0131.&nbsp;<\/p>\n\n\n\n<p><strong>Kad\u0131nlarda atipik belirtilerle kendini g\u00f6sterebiliyor<\/strong><\/p>\n\n\n\n<p>Kalp hastal\u0131klar\u0131n\u0131n kad\u0131nlarda, erkeklerde g\u00f6rd\u00fc\u011f\u00fcm\u00fcz al\u0131\u015f\u0131lm\u0131\u015f belirtiler d\u0131\u015f\u0131nda atipik tabir edilen daha farkl\u0131 belirtilerle kendini g\u00f6sterdi\u011fi vurgulanan webinarda, kad\u0131nlarda daha y\u00fcksek obezite oranlar\u0131, meme dokusu ve kalp etraf\u0131nda artm\u0131\u015f ya\u011f dokusu nedeniyle kalp hastal\u0131klar\u0131n\u0131n te\u015fhisinde kullan\u0131lan tetkik ve g\u00f6r\u00fcnt\u00fcleme y\u00f6ntemlerindeki zorluklardan ve dikkat edilmesi gereken noktalardan da bahsedildi.<\/p>\n\n\n\n<p><strong>Kansere ba\u011fl\u0131 \u00f6l\u00fcmlerin 2 kat\u0131&nbsp;<\/strong><\/p>\n\n\n\n<p><strong>TKD Y\u00f6netim Kurulu \u00dcyesi, TKD Kad\u0131n ve Kalp Sa\u011fl\u0131\u011f\u0131 Proje Grubu Koordinat\u00f6r\u00fc<\/strong>\u00a0<strong>Do\u00e7. Dr. Fahriye Vatansever A\u011fca,\u00a0<\/strong>webinara verdi\u011fi destek i\u00e7in Abdi \u0130brahim\u2019e te\u015fekk\u00fcr ederek \u015funlar\u0131 s\u00f6yledi:<strong>\u00a0\u201c<\/strong><strong>Toplumda kalp-damar hastal\u0131klar\u0131n\u0131n kad\u0131nlarda daha az g\u00f6r\u00fcld\u00fc\u011f\u00fcne dair yanl\u0131\u015f bir kan\u0131 var. Bu konuya dikkat \u00e7ekmek ve fark\u0131ndal\u0131k yaratmak amac\u0131yla, webinar i\u00e7in 8 Mart tarihini se\u00e7tik. Kardiyovask\u00fcler hastal\u0131klar \u00fclkemizde en s\u0131k \u00f6l\u00fcm nedenidir. 2022 y\u0131l\u0131 T\u00fcrkiye \u0130statistik Kurumu verilerine g\u00f6re t\u00fcm \u00f6l\u00fcmlerin \u00fc\u00e7te birinden kalp ve damar sistemi hastal\u0131klar\u0131 sorumludur ve bu toplam kanser \u00f6l\u00fcmlerinin 2 kat\u0131ndan fazlad\u0131r. T\u00dc\u0130K\u2019in 2022 verilerine g\u00f6re, kad\u0131nlarda kalp damar hastal\u0131\u011f\u0131ndan \u00f6l\u00fcm say\u0131lar\u0131na bakt\u0131\u011f\u0131m\u0131zda 88.563 gibi \u00e7arp\u0131c\u0131 bir rakama ula\u015f\u0131lmaktad\u0131r. Oysa yaln\u0131zca 4.241 kad\u0131n meme kanserinden vefat etmi\u015ftir. Bu rakamlar durumun ciddiyeti hakk\u0131nda bilgi vermektedir. Kad\u0131nlarda kalp ve damar hastal\u0131klar\u0131n\u0131n en s\u0131k g\u00f6r\u00fcld\u00fc\u011f\u00fc Avrupa \u00fclkelerinden birisi T\u00fcrkiye\u2019dir. Her 3 kad\u0131ndan biri kalp damar hastal\u0131\u011f\u0131ndan \u00f6l\u00fcrken, ancak 30 kad\u0131ndan biri meme kanserinden \u00f6lmektedir. Kad\u0131nlarda gen\u00e7 ya\u015flarda bile kalp krizinden \u00f6l\u00fcm riski, erkeklerden 2 kat fazlad\u0131r. Kalp damar hastal\u0131klar\u0131 her ya\u015ftaki kad\u0131n\u0131 etkileyebilir. Ancak menopoz d\u00f6neminde kad\u0131nl\u0131k hormonlar\u0131n\u0131n koruyucu etkisinin ortadan kalkmas\u0131 ile beraber bu risk daha da artmaktad\u0131r. Kad\u0131n-erkek fark\u0131 60 ya\u015f \u00fczerinde ortadan kalkmakta, kalp ve damar hastal\u0131klar\u0131 riski ayn\u0131 oranlarda g\u00f6r\u00fclmeye ba\u015flamaktad\u0131r. Bu nedenle kad\u0131nlarda kalp hastal\u0131klar\u0131 ile ilgili fark\u0131ndal\u0131\u011f\u0131n artmas\u0131 b\u00fcy\u00fck \u00f6nem ta\u015f\u0131maktad\u0131r.\u201d\u00a0<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>T\u00fcrkiye&#8217;nin iyile\u015ftiren g\u00fcc\u00fc Abdi \u0130brahim\u2019in ko\u015fulsuz deste\u011fi ile T\u00fcrk Kardiyoloji Derne\u011fi taraf\u0131ndan d\u00fczenlenen \u2018Kad\u0131n Kalbi\u2019 isimli webinarda, kad\u0131nlarda kalp-damar sa\u011fl\u0131\u011f\u0131 hakk\u0131nda bilgi ve veriler payla\u015f\u0131ld\u0131. TKD Y\u00f6netim Kurulu \u00dcyesi, TKD Kad\u0131n ve Kalp Sa\u011fl\u0131\u011f\u0131 Proje Grubu Koordinat\u00f6r\u00fc Do\u00e7. Dr. Fahriye Vatansever A\u011fca ve\u00a0TKD Kad\u0131n ve Kalp Sa\u011fl\u0131\u011f\u0131 Proje Grubu Ba\u015fkan\u0131 Prof. Dr. \u015eule Karakelleo\u011flu,\u00a0kalp hastal\u0131klar\u0131n\u0131n kad\u0131nlarda \u00e7ok daha seyrek g\u00f6r\u00fcld\u00fc\u011f\u00fc y\u00f6n\u00fcndeki yanl\u0131\u015f inan\u0131\u015fa dikkat \u00e7ekmek ve toplumda fark\u0131ndal\u0131k yaratmak i\u00e7in webinar\u0131 \u00f6zellikle 8 Mart D\u00fcnya Kad\u0131nlar G\u00fcn\u00fc\u2019nde d\u00fczenlediklerini ifade etti.\u00a0<\/p>\n","protected":false},"author":1,"featured_media":3003,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,3],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3002"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3002"}],"version-history":[{"count":1,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3002\/revisions"}],"predecessor-version":[{"id":3004,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3002\/revisions\/3004"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/3003"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3002"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3002"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3002"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}